Pfizer CEO Profits After COVID Vaccine Announcement

Eyebrows raised when Pfizer CEO sold some of his holdings in the company to the tune of $5.6 million. The prescheduled sale came at the perfect time, when the company publicly announced promising results from early COVID vaccine trials. CNBC reports that Bourla’s base salary was $1.65 million in April. After his most recent sale of shares, he still owns nine times his salary in shares, approximately $15 million.

MarketScale Radio hosts Daniel Litwin and Tyler Kern dissect the news. Litwin considers the serendipity of the sale timed with the public announcement. Kern and Litwin consider the thought of one person profiting tremendously off of a public good like a life-saving vaccine, and in the end, Kern points out, any one takeaway depends on how one feels about capitalism’s economic structures and incentives.

KEY POINTS:

  • Pfizer CEO Albert Bourla sells $5.6 million worth of stock just as it jumps 15%.
  • The sale was pre-scheduled, but opportunely timed with the public announcement of a promising vaccine.
  • Other medical executives at Moderna also are cashing in on spiking stocks while vaccines inch toward approval.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

SEO
SEO in the Age of AI: What CMOs and CEOs Need to Know About AEO and GEO
November 20, 2025

In an era when AI-driven search experiences are reshaping how customers discover brands, marketing leaders are navigating a confusing landscape of new acronyms, shifting behaviors, and bold industry predictions. Despite widespread claims that “SEO is dead,” the data tells a different story: organic search traffic has continued to grow even as platforms like ChatGPT, Gemini,…

Read More
From the Bench: How Research Can Help Us Build a Future-Ready Global Healthcare Workforce | Lauren Herckis | EP 18
From the Bench: How Research Can Help Us Build a Future-Ready Global Healthcare Workforce
November 20, 2025

The Care Anywhere podcast is taking listeners behind the scenes of global health workforce research with a brand-new series: From the Bench. In this kickoff episode, host Lea Sims talks with Dr. Lauren Herckis of TruMerit about how research can move from data to real-world impact — revealing how evidence, collaboration, and curiosity are driving…

Read More
purpose
Elevate Your Career Journey by Choosing Purpose, Practicing Intentionality, and Building a Culture of Belonging
November 19, 2025

Purpose doesn’t just shape what we do—it shapes how we grow. When we choose to move through our careers with intention, we start noticing the moments that build trust, the conversations that deepen understanding, and the relationships that elevate our impact. This episode of Professional Quotient digs into what it really means to show up…

Read More
Christie Linebarger
Christie Linebarger’s Journey to Leadership: Grit, Growth & Leading with Heart
November 19, 2025

Leadership conversations are shifting as companies navigate rapid change, tighter labor markets, and evolving employee expectations. Teams want leaders who show up with humility, clarity, and a genuine investment in people—traits that can’t be faked and can’t be automated. And with studies consistently linking team engagement to the quality of direct leadership, understanding how effective…

Read More